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Letters to the Editor 
Dear Editor 
Tuberculous empyema presenting after oleothorax 
Forouhi and colleagues (1) describes a 78-year-old 
man who presented in 1989 with a discharging chest 
wall sinus and an associated pleural effusion. He had 
originally been treated in 1927 with an oleothorax 
after failure of pneumothorax therapy for pulmonary 
tuberculosis. They aspirated his pleural fluid, which 
was mineral oil; on culture it yielded Mycobacterium 
tuberculosis, sensitive to the usual chemotherapeutic 
agents. Despite treatment, he died. 
The authors attribute his death to recognized com- 
plications of oleothorax therapy, but might not the 
entire illness have been avoided by a year of prophy- 
lactic isoniazid or other suitable chemotherapy, 
administered sometime in the intervening decades? 
Isn’t the real cause of death a failure of public health 
practice? 
Are there other untreated ‘old tuberculars’, 
similarly at risk? 
R. CARLEN 
17 Main Street 
Sayville 
New York 11782-2501, U.S. A. 
10 June 1994 
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Dear Editor 
Analgesia and sedation in fibre optic bronchoscopy 
We read with interest the recent short report by 
Williams et al. on the acceptability of intravenous 
midazolam for fibre optic bronchoscopy (1). How- 
ever we are somewhat surprised by the method in 
which they undertake the procedure. It is well recog- 
nized that the topical nasal anaesthesia is perceived 
as the most unpleasant part of the procedure (2), 
although this may be improved by using lignocaine 
gel (3-5). 
An alternative approach which we routinely follow 
is to give the intravenous sedation prior to applica- 
tion of 4% lignocaine solution via a Mackintosh 
atomizer. The nares are sprayed and after a few 
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minutes to allow for anaesthesia, the atomizer is 
placed in the nostrils and the patient is encouraged to 
sniff during spraying, this is usually followed by a 
small cough. Good nasal anaesthesia is achieved and 
patients appear to cough less when the cords are 
formally sprayed via the bronchoscope, probably as 
the nasal lignocaine aerosol has already partially 
anaesthetized the larynx. Moreover as the patient 
is already sedated they have no recollection of 
either the spraying of the nose or passage of the 
bronchoscope. 
The technique we describe is clean and simple to 
follow, allows a clear view, produces effective anaes- 
thesia and is exceptionally well tolerated. We would 
recommend this technique of upper airway anaesthe- 
sia and suggest that it is logical to use sedation prior 
to the most unpleasant part of the procedure. 
J. DIHENKER AND M. B. ALLEN 
St. Luke’s Hospital 
Little Horton Lane 
Bradford BD5 ONA, U.K. 
28 July 1994 
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Dear Editor 
Treatment of asthma in childhood 
In their recent paper (1) Agertoft and Pedersen 
describe 216 children with mild and moderate asthma 
who were followed for l-2 yr (run-in) before being 
given budesonide (BUD) for 3-6 yr. The dose of 
BUD started at 800 fig day ’ and was titrated up or 
down according to the degree of asthma control. The 
children receiving BUD were improved compared 
both with run-in and with a group of ‘control’ 
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